← Back to Search

Timed Intubation after Rocuronium for Endotracheal Intubation

N/A
Waitlist Available
Led By J. Ross Renew, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 15 minutes after intubation
Awards & highlights

Study Summary

This trial aims to understand how easy it is to view vocal cords and insert an endotracheal tube, and when the best time to do this is.

Who is the study for?
This trial is for patients needing elective surgery where muscle relaxants like rocuronium are used. Participants must be willing to give informed consent. It's not for those with severe kidney or liver disease, surgeries involving the arm in a sterile field, rapid sequence induction cases, wrist injuries, or neuromuscular conditions like myasthenia gravis.Check my eligibility
What is being tested?
The study is testing two different timings for endotracheal intubation after giving rocuronium: one at 2 minutes post-administration and another when only one twitch (TOFC=1) is observed. The goal is to find out which timing offers better conditions for inserting the breathing tube.See study design
What are the potential side effects?
While this trial focuses on timing rather than drug effects, potential side effects of rocuronium can include difficulty breathing, allergic reactions, changes in heart rate or blood pressure, muscle weakness and pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 15 minutes after intubation
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 15 minutes after intubation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of the intubating conditions

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intubation at TOFC=1Experimental Treatment1 Intervention
Subjects scheduled for an elective surgical procedure will have endotracheal intubation performed when muscles are almost relaxed and monitoring shows only a single count of muscle twitch (in response to a monitor that assesses muscle relaxation)
Group II: Intubation 2 minutes after rocuronium administrationActive Control1 Intervention
Subjects scheduled for an elective surgical procedure will have endotracheal intubation performed 2 minutes after the anesthesia provider gives muscle relaxing medication

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,227 Previous Clinical Trials
3,771,498 Total Patients Enrolled
J. Ross Renew, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
130 Total Patients Enrolled

Media Library

Endotracheal Intubation Clinical Trial Eligibility Overview. Trial Name: NCT05620108 — N/A
Endotracheal Intubation Research Study Groups: Intubation at TOFC=1, Intubation 2 minutes after rocuronium administration
Endotracheal Intubation Clinical Trial 2023: Endotracheal Intubation Highlights & Side Effects. Trial Name: NCT05620108 — N/A
Endotracheal Intubation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05620108 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research currently actively enrolling participants?

"This clinical trial, initially posted on November 28th 2022 and not updated since then, is currently inactive. However, there are 8 other medical studies actively recruiting participants at this time."

Answered by AI
~42 spots leftby Dec 2024